Loading...
XJPX
3079
Market cap78mUSD
Dec 05, Last price  
1,170.00JPY
1D
-0.68%
1Q
12.50%
Jan 2017
-14.66%
IPO
467.27%
Name

DVx Inc

Chart & Performance

D1W1MN
XJPX:3079 chart
P/E
29.88
P/S
0.24
EPS
39.15
Div Yield, %
4.27%
Shrs. gr., 5y
-0.04%
Rev. gr., 5y
2.42%
Revenues
50.32b
+9.75%
11,740,376,00013,080,891,00015,793,556,00018,000,829,00020,487,399,00022,872,235,00026,420,963,00028,647,863,00031,372,131,00035,266,794,00038,275,742,00040,380,089,00044,653,770,00041,007,008,00045,496,274,00047,483,757,00045,851,074,00050,321,644,000
Net income
410m
+137.18%
236,354,000277,859,000324,845,000357,145,000476,038,000682,742,000788,549,000919,948,0001,289,737,0001,025,999,000856,128,000974,181,000792,028,000572,367,000863,016,000936,184,000172,913,000410,119,000
CFO
726m
P
349,252,000337,571,000501,606,000146,382,000457,611,0001,281,412,000283,738,000515,836,0001,311,925,0001,152,166,0001,205,839,000290,272,0001,045,392,0001,743,161,0001,687,188,0001,484,945,000-422,567,000725,543,000
Dividend
Mar 30, 202650 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

DVx Inc. engages in the import/export of medical devices and related peripheral devices in Japan. The company sells arrhythmia-related products, such as cardiac pacemakers, implantable cardioverter defibrillators, electrode catheters, and ablation catheters. It also offers ischemia-related products, including excimer laser systems; RADPAD, which reduces scatter radiation exposure to medical personnel during fluoroscopy procedures; RADNEK that reduces scatter radiation exposure to the thyroid in medical personnel during fluoroscopy procedures; RADCAP, which reduces scatter radiation exposure to the head of medical personnel during fluoroscopy procedures; and resolution/resolution SD and wonder belt products. In addition, the company engages in the research, development, manufacture, sale, repair, and leasing of medical devices and related peripheral devices; provision of internal and external medical and medical device-related general consulting and services; and medical publishing and market research activities. DVx Inc. was founded in 1986 and is headquartered in Tokyo, Japan.
IPO date
Apr 25, 2007
Employees
319
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT